Cambridge Oncometrix develops a non-invasive prostate liquid biopsy test for men suspected of prostate cancer. The test is based on proprietary biomarkers and will identify men who will benefit from prostate biopsy and those who can safely forgo it.
20 January 2022
New legislation will help farmers to grow more resistant, nutritious and productive crops in the UKRead more
19 January 2022
Saving Species through genomics in megadiverse ColombiaRead more
Friday, 14/01/2022 00:00
John Innes Centre Friday Seminar – ‘Bacteria-phage warfare’Read more